Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Precision Biosciences (DTIL) Return on Capital Employed (2019 - 2025)

Historic Return on Capital Employed for Precision Biosciences (DTIL) over the last 7 years, with Q3 2025 value amounting to 1.04%.

  • Precision Biosciences' Return on Capital Employed fell 9300.0% to 1.04% in Q3 2025 from the same period last year, while for Sep 2025 it was 1.04%, marking a year-over-year decrease of 9300.0%. This contributed to the annual value of 0.2% for FY2024, which is 1000.0% up from last year.
  • Per Precision Biosciences' latest filing, its Return on Capital Employed stood at 1.04% for Q3 2025, which was down 9300.0% from 0.87% recorded in Q2 2025.
  • Precision Biosciences' 5-year Return on Capital Employed high stood at 0.05% for Q2 2024, and its period low was 1.04% during Q3 2025.
  • Moreover, its 5-year median value for Return on Capital Employed was 0.33% (2023), whereas its average is 0.39%.
  • As far as peak fluctuations go, Precision Biosciences' Return on Capital Employed soared by 7300bps in 2021, and later crashed by -9300bps in 2025.
  • Over the past 5 years, Precision Biosciences' Return on Capital Employed (Quarter) stood at 0.21% in 2021, then crashed by -100bps to 0.43% in 2022, then increased by 9bps to 0.39% in 2023, then surged by 48bps to 0.2% in 2024, then plummeted by -415bps to 1.04% in 2025.
  • Its Return on Capital Employed was 1.04% in Q3 2025, compared to 0.87% in Q2 2025 and 0.37% in Q1 2025.